Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current approach to cancer treatment. Although the use of ICIs has become the standard of care for advanced melanoma, reports of ICI use among Asian populations with melanoma are limited. Therefore, we conducted this retr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Wu, Chiao-En, Yang, Chan-Keng, Peng, Meng-Ting, Huang, Pei-Wei, Lin, Yu-Fen, Cheng, Chi-Yuan, Chang, Yao-Yu, Chen, Huan-Wu, Hsieh, Jia-Juan, Chang, John Wen-Cheng
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7287159/
https://ncbi.nlm.nih.gov/pubmed/32582554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00905
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы